|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
GB9310030D0
(en)
*
|
1993-05-15 |
1993-06-30 |
Scras |
Dry processed particles and process for the preparation of the same
|
|
US5569467A
(en)
*
|
1993-05-15 |
1996-10-29 |
Societe De Conseils De Recherches Et D'applications (S.C.R.A.S.) |
Process for the preparation of microballs and microballs thus obtained
|
|
WO1995022963A1
(en)
*
|
1994-02-28 |
1995-08-31 |
Medinova Medical Consulting Gmbh |
Drug targeting system, method for preparing same and its use
|
|
US5980945A
(en)
*
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
|
DE19604744A1
(de)
|
1996-02-09 |
1997-08-14 |
Henkel Kgaa |
Technische Di-/Triglyceridgemische
|
|
DE19617137C1
(de)
*
|
1996-04-29 |
1997-02-27 |
Henkel Kgaa |
Verwendung von Copolymerestern für die Herstellung von Mikrosphären
|
|
EP0930874A2
(en)
*
|
1996-10-09 |
1999-07-28 |
Takeda Chemical Industries, Ltd. |
A method for producing a microparticle
|
|
MY118835A
(en)
*
|
1997-04-18 |
2005-01-31 |
Ipsen Pharma Biotech |
Sustained release compositions and the process for their preparation
|
|
WO1999052708A1
(en)
|
1998-04-13 |
1999-10-21 |
Luminex Corporation |
Liquid labeling with fluorescent microparticles
|
|
ATE303795T1
(de)
*
|
1998-12-16 |
2005-09-15 |
Aventis Pharma Inc |
In biologisch abbaubare polymere eingekapselter serotoninrezeptor-antagonist und deren herstellungsverfahren
|
|
AU5644400A
(en)
*
|
1999-09-24 |
2001-03-29 |
Rohm And Haas Company |
Pellet compositions
|
|
US6458387B1
(en)
*
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
|
ATE430558T1
(de)
|
2000-10-27 |
2009-05-15 |
Baxter Healthcare Sa |
Herstellung von mikrokügelchen
|
|
US20030064033A1
(en)
*
|
2001-08-16 |
2003-04-03 |
Brown Larry R. |
Propellant-based microparticle formulations
|
|
US20080026068A1
(en)
*
|
2001-08-16 |
2008-01-31 |
Baxter Healthcare S.A. |
Pulmonary delivery of spherical insulin microparticles
|
|
US20040166077A1
(en)
*
|
2002-12-04 |
2004-08-26 |
L'oreal |
Process for treating keratin materials with aromatic active principles
|
|
FR2848113B1
(fr)
*
|
2002-12-04 |
2005-02-25 |
Oreal |
Stabilisation de principes actifs aromatiques par des polymeres aromatiques
|
|
US20050142205A1
(en)
*
|
2003-07-18 |
2005-06-30 |
Julia Rashba-Step |
Methods for encapsulating small spherical particles prepared by controlled phase separation
|
|
US20070092452A1
(en)
*
|
2003-07-18 |
2007-04-26 |
Julia Rashba-Step |
Methods for fabrication, uses, compositions of inhalable spherical particles
|
|
BRPI0412735A
(pt)
*
|
2003-07-18 |
2006-09-26 |
Baxter Int |
métodos para a fabricação, uso e composição de partìculas esféricas pequenas preparadas mediante a separação de fase controlada
|
|
JP2007508240A
(ja)
*
|
2003-07-22 |
2007-04-05 |
バクスター・インターナショナル・インコーポレイテッド |
低分子量有機分子の小球状粒子ならびにその調製方法および使用方法
|
|
US20060135277A1
(en)
*
|
2003-09-10 |
2006-06-22 |
Marnocha Bendict F |
Golf club and practice arrangement
|
|
FR2865938B1
(fr)
*
|
2004-02-05 |
2006-06-02 |
Sod Conseils Rech Applic |
Formulation retard solide comprenant de l'acetate de triptoreline
|
|
US8728525B2
(en)
*
|
2004-05-12 |
2014-05-20 |
Baxter International Inc. |
Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
|
|
MXPA06012992A
(es)
*
|
2004-05-12 |
2007-02-12 |
Baxter Int |
Microesferas que comprenden proteina y que muestran inyectabilidad en altas concentraciones de este agente.
|
|
CA2566199C
(en)
*
|
2004-05-12 |
2013-10-22 |
Baxter International Inc. |
Delivery of as-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
|
|
EP1765294B1
(en)
|
2004-05-12 |
2008-09-24 |
Baxter International Inc. |
Nucleic acid microspheres, production and delivery thereof
|
|
AU2005271781A1
(en)
*
|
2004-07-13 |
2006-02-16 |
Altairnano, Inc. |
Ceramic structures for prevention of drug diversion
|
|
AU2005271782A1
(en)
*
|
2004-07-13 |
2006-02-16 |
Altairnano, Inc. |
Ceramic structures for controlled release of drugs
|
|
JP2008528443A
(ja)
*
|
2004-10-29 |
2008-07-31 |
アドヒーシブズ・リサーチ・インコーポレイテッド |
セキュリティ・アイデンティフィケーションのための微視的なタグ付けシステム
|
|
EP1885335A1
(en)
*
|
2005-04-27 |
2008-02-13 |
BAXTER INTERNATIONAL INC. (a Delaware corporation) |
Surface-modified microparticles and methods of forming and using the same
|
|
EP1928814A2
(en)
*
|
2005-08-23 |
2008-06-11 |
Altairnano, Inc |
HIGHLY PHOTOCATALYTIC PHOSPHORUS-DOPED ANATASE-TiO2 COMPOSITION AND RELATED MANUFACTURING METHODS
|
|
WO2007103820A1
(en)
*
|
2006-03-02 |
2007-09-13 |
Altairnano, Inc. |
Nanostructured indium-doped iron oxide
|
|
WO2007103824A1
(en)
*
|
2006-03-02 |
2007-09-13 |
Altairnano, Inc. |
Nanostructured metal oxides
|
|
US20080038482A1
(en)
*
|
2006-03-02 |
2008-02-14 |
Fred Ratel |
Method for Low Temperature Production of Nano-Structured Iron Oxide Coatings
|
|
US20070281031A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Guohan Yang |
Microparticles and methods for production thereof
|
|
CN101500616A
(zh)
|
2006-08-04 |
2009-08-05 |
巴克斯特国际公司 |
预防和/或逆转新发作自身免疫糖尿病的基于微球的组合物
|
|
WO2008060786A2
(en)
*
|
2006-10-06 |
2008-05-22 |
Baxter International Inc. |
Microencapsules containing surface-modified microparticles and methods of forming and using the same
|
|
AU2007306936B2
(en)
|
2006-10-12 |
2014-02-06 |
The University Of Queensland |
Compositions and methods for modulating immune responses
|
|
US20090169628A1
(en)
|
2006-10-17 |
2009-07-02 |
Armark Authentication Technologies, Llc |
Article and method for focused delivery of therapeutic and/or diagnostic materials
|
|
US20080254258A1
(en)
*
|
2007-04-12 |
2008-10-16 |
Altairnano, Inc. |
Teflon® replacements and related production methods
|
|
CN101686939B
(zh)
*
|
2007-04-17 |
2013-03-27 |
巴克斯特国际公司 |
用于肺部投送的核酸微粒
|
|
US9782300B2
(en)
|
2008-02-01 |
2017-10-10 |
Kci Licensing, Inc. |
Fiber-microsphere bioresorbable composite scaffold for wound healing
|
|
ES2686708T3
(es)
|
2008-04-18 |
2018-10-19 |
Baxter International Inc. |
Composición basada en microesferas para prevenir y/o revertir la diabetes autoinmune de nueva aparición
|
|
US8323615B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing multi-phasic dispersions
|
|
US20100047292A1
(en)
*
|
2008-08-20 |
2010-02-25 |
Baxter International Inc. |
Methods of processing microparticles and compositions produced thereby
|
|
US8323685B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
|
US8367427B2
(en)
*
|
2008-08-20 |
2013-02-05 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
|
WO2010037021A2
(en)
*
|
2008-09-29 |
2010-04-01 |
Armark Authentication Technologies, Llc |
Spinneret and method of spinning fiber
|
|
US20100291214A1
(en)
*
|
2008-12-23 |
2010-11-18 |
Armark Authentication Technologies, Llc |
Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
|
|
US20100291384A1
(en)
*
|
2009-05-15 |
2010-11-18 |
Armark Authentication Technologies, Llc |
Fiber having non-uniform composition and method for making same
|
|
BRPI1012036A2
(pt)
|
2009-05-27 |
2017-10-10 |
Selecta Biosciences Inc |
nanocarreadores que possuem componentes com diferentes taxas de liberação
|
|
US20110076771A1
(en)
*
|
2009-09-25 |
2011-03-31 |
Armark Authentication Technologies, Llc |
Tissue fiber scaffold and method for making
|
|
CA2798739A1
(en)
|
2010-05-26 |
2011-12-01 |
Selecta Biosciences, Inc. |
Nanocarrier compositions with uncoupled adjuvant
|
|
EP2399931A1
(fr)
*
|
2010-06-22 |
2011-12-28 |
Ipsen Pharma S.A.S. |
Nouveaux composés octapeptidiques et leur utilisation thérapeutique
|
|
US11311610B2
(en)
|
2010-11-01 |
2022-04-26 |
University Of Technology Sydney |
Immune-modulating agents and uses therefor
|
|
KR20140050698A
(ko)
|
2011-07-29 |
2014-04-29 |
셀렉타 바이오사이언시즈, 인크. |
체액성 및 세포독성 t 림프구(ctl) 면역 반응을 발생시키는 합성 나노운반체
|
|
US10695406B2
(en)
|
2014-05-27 |
2020-06-30 |
The University Of Queensland |
Modulation of cellular stress using a B-cell oxidative and/or endoplasmic reticulum stress inhibitor and a targeting agent
|
|
FR3067226B1
(fr)
*
|
2017-06-13 |
2021-10-08 |
Rossignol Lange |
Element de chaussure de ski
|